SHSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/07/2026 15:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization4,024.67 mln
Float247 mln
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.62
Likely reliable
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.51
Moderate leverage
ROE
-24.78
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2003 and headquartered in Shannan, China, Lionco Pharmaceutical Group develops and sells a wide range of medicines across the country. Its products address many common and serious health conditions, including heart disease, infections, digestive disorders, and cancer.
